Tate & Lyle posted a 16% rise in underlying profit yesterday (25 May) with a strong performance from artificial sweetener Sucralose and US growth helping to offset a weaker performance in European markets. However, a one-off exceptional impairment charge relating to changes to the European sugar regime hit profits hard.